Which tape spares baby skin? trial pits water-based against hydrocolloid barrier tapes

NCT ID NCT04802694

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a water-based barrier tape or a hydrocolloid barrier tape better protects the skin of babies aged 4–6 weeks who need a nasogastric tube. Researchers compare skin integrity after removing the tape, aiming to find which product causes less irritation. The trial involves 108 hospitalized infants without existing skin conditions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
water-based barrier tape or hydrocolloid barrier tape
What this could lead to
If water-based barrier tape works better, it could become the standard way to protect baby skin during nasogastric tube use.
What could go wrong
This is a small, early-stage study with only 108 babies, so results may not apply to all infants or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Oct 2020

Finished

Oct 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 6 weeks

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All the 4-6 weeks infants including interventional process and without any skin diseases Exclusion Criteria: * The infants receiving treatment without any interventional process * Those having a skin disease * Those infants having PICC and SVK catheters and do not meet the required criteria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Giresun University Women and Children's Hospital

    Giresun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.